Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present RespireRx Pharmaceuticals Inc. (OTC: RSPI).

Full DD Report for RSPI

You must become a subscriber to view this report.


Recent News from (OTC: RSPI)

RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data:
Effects of Chronic Systemic Low-impact Ampakine Treatment on  Neurotrophin Expression in Rat Brain Glen Rock, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announc...
Source: GlobeNewswire
Date: July, 25 2018 09:00
RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso
Glen Rock, N.J, June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. announces the decision of Dr. James S. Manuso to resign as president, CEO, Vice Chairman and member of the Board of Directors (“Board”) of the Company, effective as of September 30, 2018, the expi...
Source: GlobeNewswire
Date: June, 19 2018 16:13
Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply Agreement with Noramco, Inc.
Glen Rock, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that on June 13, 2018, it entered into a letter of intent (“LOI”) with Noramco, Inc., pursuant to ...
Source: GlobeNewswire
Date: June, 19 2018 08:45
5 of Today's Biggest Marijuana Stock Gainers - Tuesday, January 30th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Tuesday, January 30th including Digipath, Inc. (OTC:DIGP) and more... CLS Holdings USA, Inc. (OTC:CLSH) Shares of CLS Holdings USA, Inc. rose 9.33% on the OTC markets on higher than ave...
Source: Daily Marijuana Observer
Date: January, 30 2018 17:38
RespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase(TM) 2018
CEO to Review completed Phase IIB dronabinol trial for the treatment of Obstructive Sleep Apnea (OSA) and Provide Pipeline update Glen Rock, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC QB: RSPI) (“RespireRx” or the “Company”), ...
Source: GlobeNewswire
Date: January, 08 2018 08:45
5 of Today's Biggest Marijuana Stock Losers - Friday, December 29th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock losers in trading on Friday, December 29th including Namaste Technologies Inc. (CSE:N) (OTC:NXTTF) and more... Golden Leaf Holdings Ltd. (CSE:GLH) (OTC:GLDFF) Shares of Golden Leaf Holdings Ltd. dropped 9.66% to...
Source: Daily Marijuana Observer
Date: December, 29 2017 16:53
5 of Today's Biggest Marijuana Stock Losers - Tuesday, December 26th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock losers in trading on Tuesday, December 26th including MariMed Inc. (OTC:MRMD) and more... Gridiron BioNutrients, Inc. (OTC:GMVP) Shares of Gridiron BioNutrients, Inc. dropped 21.67% today on lower than average ...
Source: Daily Marijuana Observer
Date: December, 26 2017 18:41
5 of Today's Biggest Marijuana Stock Losers - Tuesday, December 19th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock losers in trading on Tuesday, December 19th including Innovative Industrial Properties, Inc. (NYSE:IIPR) and more... Abattis Bioceuticals Corp. (OTC:ATTBF) (CSE:ATT) Shares of Abattis Bioceuticals Corp. dropped ...
Source: Daily Marijuana Observer
Date: December, 19 2017 18:35
5 of Today's Biggest Marijuana Stock Gainers - Monday, December 18th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Monday, December 18th including Canopy Growth Corporation (TSX:WEED) (OTC:TWMJF) and more... Canopy Growth Corp. (TSX:WEED) (OTC:TWMJF) Shares of Canopy Growth Corp. rose 6.45% on the OTC m...
Source: Daily Marijuana Observer
Date: December, 18 2017 22:30
RespireRx Pharmaceuticals Inc. Publishes Compelling Scientific Evidence Demonstrating the Neurobiological Safety of Ampakine CX717 and Justifying Continued Clinical Development
Glen Rock, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that a paper detailing the neurobiologic safety of the ampakine CX717 has been accepted for publication by Toxic...
Source: GlobeNewswire
Date: December, 18 2017 08:45

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.70N/AN/A3
2018-12-13N/A0.70N/AN/A5
2018-12-12N/A0.70N/AN/A0
2018-12-110.7050.700.7050.702,441
2018-12-10N/A0.70N/AN/A56

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-111,0002,44140.9668Short
2018-12-07338338100.0000Short
2018-12-0610020648.5437Short
2018-11-305072,34621.6113Cover
2018-11-01306347.6190Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RSPI.


About RespireRx Pharmaceuticals Inc. (OTC: RSPI)

Logo for RespireRx Pharmaceuticals Inc. (OTC: RSPI)

RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug induced respiratory depression and other brain mediated breathing disorders.

 

Contact Information

 

 

Current Management

  • James S. J. Manuso / President, CEO
    • Dr. Manuso is the former Chairman of the Board of Directors and Chief Executive Officer of Astex Pharmaceuticals, Inc. NASDAQ: ASTX , having served in such positions from July through October . Dr. Manuso had previously served as the President and Chief Executive Officer, as well as Chairman of the Board of Directors, of Astex formerly SuperGen, Inc.: NASDAQ: SUPG from January to July , and as a director of Astex since February .
  • Jeff E. Margolis / CFO, Senior VP, Secretary
  • Richard D. Purcell, Jr. / SVP, R amp D
  • Arnold S. Lippa / CSO
  • Arnold S. Lippa / Chairman
  • Kathryn MacFarlane /
  • James S. J. Manuso / Director
    • Dr. Manuso is the former Chairman of the Board of Directors and Chief Executive Officer of Astex Pharmaceuticals, Inc. NASDAQ: ASTX , having served in such positions from July through October . Dr. Manuso had previously served as the President and Chief Executive Officer, as well as Chairman of the Board of Directors, of Astex formerly SuperGen, Inc.: NASDAQ: SUPG from January to July , and as a director of Astex since February .
  • Jeff E. Margolis /
  • James Sapirstein /

Current Share Structure

  • Market Cap: $3,448,917 - 03/16/2018
  • Authorized: 65,000,000 - 09/30/2016
  • Issue and Outstanding: 2,632,761 - 11/13/2017

 


Recent Filings from (OTC: RSPI)

Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 15 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 11 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 14 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 20 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: November, 14 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 03 2017

 

 


Daily Technical Chart for (OTC: RSPI)

Daily Technical Chart for (OTC: RSPI)


Stay tuned for daily updates and more on (OTC: RSPI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: RSPI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RSPI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RSPI and does not buy, sell, or trade any shares of RSPI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/